Nucelion is a next-generation Cell & Gene Therapy CDMO helping innovators accelerate their journey from discovery to clinical impact. With deep expertise in viral vectors (AAV, Lentivirus) and cell therapies (CAR-T, NK, iPSC-derived), we bring scientific precision and operational discipline under one roof.

Were Scientists First, Operators Always

Were Scientists First, Operators Always

Were Scientists First, Operators Always

Dr. Raghu Malapaka

CBO –Nucelion Therapeutics

Raghu Malapaka, Ph.D, CBO, Nucelion. Dr. Raghu Malapaka has an extensive commercial experience in the development and manufacturing of large molecules as well as advanced therapies. He served in leadership roles in global CDMOs including AGC Bio, Thermofisher and WuXi and played key role in bringing some of the earliest CGTs to the patients. He has a PhD in molecular biology and post-doctoral experience at Harvard Medical School.

What Makes Us Different

End-to-end mindset

Process + Analytics + Quality + Program Management in one loop, not siloed.

Right-sized capacity

~30,000 sft Dev Labs, GMP Suites, QC & Fill-Finish supporting AAV (2 campaigns/mo, 75–150 L), LVV (1–2/mo), CAR-T (10–20 lots/mo), and Plasmid (2–3 GMP lots/mo, 10–20 L & 75–150 L).

Regulatory pragmatism

CMC packages that actually pass muster—IND/IMPD-oriented documentation, ALCOA+ data integrity, and phase-appropriate validation.

Transparent Project Management

You’ll see Gantt updates, risk registers, and burn-rate vs. deliverables

What Makes Us Different

End-to-end mindset

Process + Analytics + Quality + Program Management in one loop, not siloed.

Right-sized capacity

~30,000 sft Dev Labs, GMP Suites, QC & Fill-Finish supporting AAV (2 campaigns/mo, 75–150 L), LVV (1–2/mo), CAR-T (10–20 lots/mo), and Plasmid (2–3 GMP lots/mo, 10–20 L & 75–150 L).

Regulatory pragmatism

CMC packages that actually pass muster—IND/IMPD-oriented documentation, ALCOA+ data integrity, and phase-appropriate validation.

Transparent Project Management

You’ll see Gantt updates, risk registers, and burn-rate vs. deliverables

Where We Operate

We’re headquartered in Genome Valley, Hyderabad, India, with GMP manufacturing, QC, and development labs under one roof.

Our location within India’s premier biotech hub provides access to world-class scientific talent, infrastructure, and collaboration opportunities that drive every program forward.

We partner with hospitals, biotech startups, and pharmaceutical companies that value responsiveness, precision, and accountability.

We do not oversell capacity — what we promise, we deliver.

Our Mission

Bring world-class CGT manufacturing within reach — technically rigorous, ethically responsible, and economically sane.

Lets Build the Future of Advanced Therapies, Together.

Lets Build the Future of Advanced Therapies, Together.

Copyright © 2025 Nucelion All rights reserved.

Copyright © 2025 Nucelion All rights reserved.

Copyright © 2025 Nucelion All rights reserved.